The incretin class of peptides has generated more mainstream attention than perhaps any other category of research compounds in the past decade. Semaglutide, tirzepatide, and retatrutide — representing mono-agonist, dual-agonist, and triple-agonist approaches respectively — have been studied extensively in clinical trials focused on metabolic function and body composition. This article provides a factual overview of all three compounds, their mechanisms, and how they compare

Canada has quietly become one of the most active markets for peptide research in North America. From university laboratories studying tissue repair mechanisms to clinical trial programs investigating metabolic peptides, the scope of peptide science in Canada continues to expand. This article provides an overview of the key compounds driving research interest and why peptide science has gained so much momentum. Why Peptides Are a Growing Area of Scientific Interest Peptides oc

GHK-Cu is one of the most extensively studied peptides in anti-aging research, with over 100 published studies spanning five decades. The GLOW Blend is a multi-peptide formulation that combines GHK-Cu with two additional research peptides — BPC-157 and TB-500. Both are available from Durham Peptides, and researchers frequently ask which option is more appropriate for their work. This article compares the two products across their composition, mechanisms, and research applicat

The incretin peptide class has evolved rapidly. In the span of a few years, metabolic peptide research has progressed from single-receptor compounds to dual-receptor and now triple-receptor agonists. Semaglutide, tirzepatide, and retatrutide represent three generations of this progression — each building on the pharmacological foundation of the last. This article compares all three compounds across their receptor pharmacology, clinical data, and research implications. The Cor

BPC-157 and TB-500 recovery research peptide comparison Durham Peptides Canada BPC-157 and TB-500 are the two most discussed recovery-related research peptides in Canada. Both are studied for their roles in tissue repair, and both appear regularly in research forums, biohacking communities, and scientific literature. But despite their frequent comparison, they are fundamentally different compounds with distinct mechanisms of action. This article provides a factual comparison

Semaglutide peptide vial from Durham Peptides Canada Semaglutide and tirzepatide are two of the most discussed peptide compounds in modern biomedical research. Both belong to the incretin class of peptides — compounds that mimic or enhance the body's natural gut hormones involved in metabolic regulation. While they share some common ground, their mechanisms of action are fundamentally different, which is why researchers frequently compare them in head-to-head studies. This ar

Two categories of research compounds dominate discussions in fitness, biohacking, and longevity communities: peptides and SARMs (Selective Androgen Receptor Modulators). While they're often mentioned in the same breath, they are fundamentally different in their molecular structure, mechanisms of action, and regulatory status. This article provides a factual comparison of the two categories. What Are Peptides? Peptides are short chains of amino acids — the same building blocks

The intersection of peptide science and aging biology has become one of the most active research areas in the longevity field. Several peptide compounds have been extensively studied for their effects on cellular processes associated with aging — including collagen production, gene expression regulation, mitochondrial function, and tissue regeneration. This article provides a research-focused overview of the four most studied anti-aging peptides available to the research comm